Sentynl Therapeutics Inc. ("Sentynl"), a U.S.-based biopharmaceutical company and wholly-owned subsidiary of Zydus Lifesciences Limited ("Zydus"), announced that it is entering into an agreement with ...

Now that we are a week into free agency, and we got a glimpse into the vision that Mike Vrabel and the front office have for ...

The Detroit Lions have already been active retooling their roster this offseason. Yet, there is certainly more work to do to get the Lions back to the playoffs in 2026.